2001
DOI: 10.1021/ic0001053
|View full text |Cite
|
Sign up to set email alerts
|

Dimeric W3SO3 Cluster Complexes:  Synthesis, Characterization, and Potential Applications as X-ray Contrast Agents

Abstract: Our continued research on the use of heavy metal cluster complexes as a new class of X-ray contrast agents in medical diagnostic imaging is described. A series of 2:3 cluster-ligand complexes, [(W(IV)3SO3)2L3]4- (L = linear polyaminopolycarboxylate ligands), were isolated from the reaction of aqua ion [W(IV)3SO3(H2O)9]4- (prepared in large quantities through an improved literature process) with respective ligands in refluxing DMF. The salts of [(W(IV)3SO3)2L3]4- complex anions were fully characterized using ro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2002
2002
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(11 citation statements)
references
References 23 publications
0
11
0
Order By: Relevance
“…A major limitation of our currently available clinical contrast agents is that they are all based on iodine and barium – these two materials have similar low to high kVp attenuation ratios (hereafter referred to as ‘attenuation ratios’) and their signals cannot be reliably separated in clinical DECT . High atomic number elements attenuate X‐rays well, and many of these elements have been explored in the past as potential X‐ray or CT imaging contrast agents, including bismuth, gold, cesium, tin, tantalum, tungsten, and lanthanides . Representative contrast compounds include prototypic tantalum oxide colloids described as intravenous X‐ray contrast agents in dogs and rabbits in 1972 , well‐defined tantalum oxide nanoparticles recently used as intravenous contrast agents for CT , tungsten cluster compounds as intravenous contrast agents for CT , bismuth sulfide nanoparticles for blood pool imaging , and organic bismuth‐compound‐encapsulated polymeric nanoparticles for both intravascular thrombosis imaging and spectral CT imaging applications .…”
Section: Introductionmentioning
confidence: 99%
“…A major limitation of our currently available clinical contrast agents is that they are all based on iodine and barium – these two materials have similar low to high kVp attenuation ratios (hereafter referred to as ‘attenuation ratios’) and their signals cannot be reliably separated in clinical DECT . High atomic number elements attenuate X‐rays well, and many of these elements have been explored in the past as potential X‐ray or CT imaging contrast agents, including bismuth, gold, cesium, tin, tantalum, tungsten, and lanthanides . Representative contrast compounds include prototypic tantalum oxide colloids described as intravenous X‐ray contrast agents in dogs and rabbits in 1972 , well‐defined tantalum oxide nanoparticles recently used as intravenous contrast agents for CT , tungsten cluster compounds as intravenous contrast agents for CT , bismuth sulfide nanoparticles for blood pool imaging , and organic bismuth‐compound‐encapsulated polymeric nanoparticles for both intravascular thrombosis imaging and spectral CT imaging applications .…”
Section: Introductionmentioning
confidence: 99%
“…The acidic methine protons of unsubstituted or monoalkylated malononitrile derivatives have been reported to be the cause of poor yields during reduction. Chemical reductions using NaBH 4 /BF 3 −Et 2 O, NaBH 4 /NiCl 2 , LAH, or LAH/AlCl 3 did not proceed cleanly, nor did catalytic reduction using PtO 2 in EtOH/CHCl 3 . Hydrogenations with Pd/C in EtOH or in an acidic medium were also unsuccessful; even with the possibility of side reactions of amines with partially reduced imine intermediates being suppressed. …”
Section: Resultsmentioning
confidence: 99%
“…[50][51][52] Chemical reductions using NaBH 4 /BF 3 -Et 2 O, 53 NaBH 4 /NiCl 2 , 54 LAH, 55 or LAH/AlCl 3 56 did not proceed cleanly, nor did catalytic reduction using PtO 2 in EtOH/CHCl 3 . 57 Hydrogenations with Pd/C in EtOH or in an acidic medium 58 were also unsuccessful; even with the possibility of side reactions of amines with partially reduced imine intermediates 59 being suppressed.…”
Section: ' Results and Discussionmentioning
confidence: 99%
“…Further progress is reported in the development of tungsten clusters as X-ray opaque contrast agents with the synthesis of compounds [(W 3 O 3 S) 2 L 3 ] 4Ϫ (L = linear polyaminopolycarboxylate ligands) containing the triangular W IV cluster unit {W 3 O 3 S} 4ϩ . 211 The known insulin mimetic effects of tungstate 212 led to polyoxotungstate clusters being evaluated as insulin mimetics in animal models. 213…”
Section: Tungstenmentioning
confidence: 99%